Literature DB >> 11678319

The effect of electrostimulation and high load exercises in patients with patellofemoral joint dysfunction. A preliminary report.

R Vengust1, V Strojnik, V Pavlovcic, V Antolic, O Zupanc.   

Abstract

Traditional conservative treatment for patellar disorders is successful in about 80 percents of cases. We introduced two new conservative treatment protocols for patellar pathology in order to further improve the success rate. The first protocol consisted of high load/low repetition quadriceps femoris training (10 patients) while the second enclosed selective electrostimulation of vastus medialis muscle (7 patients). Results were evaluated clinically and neurophysiologically. High load/low repetition training resulted in significant increase of maximal voluntary contraction of quadriceps muscle (P < 0.001). Significant gain of Activity (P = 0.017) and Kujala scores (P = 0.07) was observed in group with high load/low repetition quadriceps training compared to patients with electrostimulation. There was no significant change in neurophysiological or clinical status between the beginning and the end of treatment with electrostimulation. Our results indicate that high load/low repetition quadriceps femoris training poses an important alternative to traditional conservative treatment protocol for patellar disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11678319     DOI: 10.1007/s004240100004

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  2 in total

Review 1.  Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome.

Authors:  Ana Luiza C Martimbianco; Maria Regina Torloni; Brenda Ng Andriolo; Gustavo Jm Porfírio; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2017-12-12

Review 2.  Combined application of neuromuscular electrical stimulation and voluntary muscular contractions.

Authors:  Thierry Paillard
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.